173 related articles for article (PubMed ID: 35098448)
1. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.
Lu H; Zhu C; Chen Y; Ruan Y; Fan L; Chen Q; Wei Q
Clin Transl Oncol; 2022 Jun; 24(6):1124-1133. PubMed ID: 35098448
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
3. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.
Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH
Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210
[TBL] [Abstract][Full Text] [Related]
6. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Liu D; Zhang M; Song Y; Yang N
Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
[TBL] [Abstract][Full Text] [Related]
7. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
8. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein.
Zhang X; Zhang X; Yang G; Wan L; Yin F; Li H; Yin D
Biochem Biophys Res Commun; 2023 Aug; 669():95-102. PubMed ID: 37267865
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.
Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y
Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304
[TBL] [Abstract][Full Text] [Related]
12. [Long non-coding RNA ABHD11-AS1 promotes glycolysis in gastric cancer cells to accelerate tumor progression].
Feng W; Lai Y; Wang J; Xu P
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1485-1492. PubMed ID: 37814862
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
Chen Y; Li Y; Gao H
Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
[TBL] [Abstract][Full Text] [Related]
15. lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
Zeng XY; Jiang XY; Yong JH; Xie H; Yuan J; Zeng D; Dou YY; Xiao SS
Cancer Med; 2019 Nov; 8(16):7074-7085. PubMed ID: 31568657
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway.
He D; Yue Z; Liu L; Fang X; Chen L; Han H
J Cell Physiol; 2019 Jul; 234(7):12070-12079. PubMed ID: 30537177
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
18. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs SET-binding factor 2-antisense RNA1 promotes cell growth through targeting miR-431-5p/CDK14 axis in human papillary thyroid cancer.
Wen HL; Xu ZM; Wen D; Lin SY; Liang Y; Xie JP
Kaohsiung J Med Sci; 2020 Oct; 36(10):808-816. PubMed ID: 32602632
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
